AĆIMOVIĆ, Ivana, Viktorie GABRIELOVÁ, Riza Can CAKMAKCI, Lukáš PEČINKA, Lukáš MORÁŇ, Martina VODINSKÁ, Vendula PELKOVÁ, Michal EID, Petr MORAVČÍK, Jakub VLAŽNÝ, Zdeněk KALA a Petr VAŇHARA. Endoplasmic reticulum stress response of patient-derived pancreatic ductal adenocarcinoma cells. In BIOCEV Regeneration III. 2023.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Endoplasmic reticulum stress response of patient-derived pancreatic ductal adenocarcinoma cells
Název anglicky Endoplasmic reticulum stress response of patient-derived pancreatic ductal adenocarcinoma cells
Autoři AĆIMOVIĆ, Ivana (688 Srbsko, domácí), Viktorie GABRIELOVÁ (203 Česká republika, domácí), Riza Can CAKMAKCI (792 Turecko, domácí), Lukáš PEČINKA (203 Česká republika, domácí), Lukáš MORÁŇ (203 Česká republika, domácí), Martina VODINSKÁ (203 Česká republika, domácí), Vendula PELKOVÁ (203 Česká republika, domácí), Michal EID (203 Česká republika, domácí), Petr MORAVČÍK (203 Česká republika, domácí), Jakub VLAŽNÝ (203 Česká republika, domácí), Zdeněk KALA (203 Česká republika, domácí) a Petr VAŇHARA (203 Česká republika, garant, domácí).
Vydání BIOCEV Regeneration III, 2023.
Další údaje
Originální jazyk čeština
Typ výsledku Konferenční abstrakt
Obor 30400 3.4 Medical biotechnology
Stát vydavatele Česká republika
Utajení není předmětem státního či obchodního tajemství
Kód RIV RIV/00216224:14110/23:00134677
Organizační jednotka Lékařská fakulta
Klíčová slova anglicky PDAC; endoplasmic reticulum; unfolded protein response; mass spectrometry
Změnil Změnil: doc. RNDr. Petr Vaňhara, Ph.D., učo 43385. Změněno: 24. 11. 2023 07:52.
Anotace
INTRODUCTION Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer. PDAC patients are usually diagnosed with advanced stage of the disease and with poor prognosis due to lack of early biomarkers and insufficient treatments. The epithelial to mesenchymal transition (EMT) has been recognized as a driver of PDAC progression. Also, in recent years, endoplasmic reticulum (ER) stress has been correlated with PDAC. Unfolded protein response (UPR) is the main signaling pathway that is activated by ER overload. We aimed to investigate the ER stress response in patient-derived PDAC cells as a potential target for future therapeutic approaches. METHODS Primary PDAC cell cultures were established from resected tumors of PDAC patients. The ER stress in patient-derived PDAC cells as well as in PANC-1 cell line was induced by tunicamycin treatment for 24 h. The ER stress cellular response was evaluated by immunofluorescence microscopy and western blot analysis. We analyzed the expression levels of two signaling molecules involved in canonical UPR: ER chaperone the binding immunoglobulin protein (BiP) and the C/EBP homologous protein (CHOP). Also, we evaluated the expression levels of epithelial (E-) and neural (N-) cadherins as markers of EMT. To assess the chemical fingerprint of PDAC cells under the ER stress, we applied the intact cell matrix assisted laser desorption/ionization - time of flight mass spectrometry (MALDI-TOF MS). RESULTS AND CONCLUSION We characterized the UPR in PDAC patient-derived cells and in PANC-1 cell line at basal level and after induction of ER stress. MALDI-TOF MS was shown as a valuable tool for assessment of PDAC heterogeneity with potential of revealing the unique metabolic signature of the PDAC patients. Acknowledgements: This study was supported by AZV ČR (NU23-08-00241) and by Masaryk University (MUNI/A/1301/2022 and MUNI/11/ACC/3/2022)
Anotace anglicky
INTRODUCTION Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer. PDAC patients are usually diagnosed with advanced stage of the disease and with poor prognosis due to lack of early biomarkers and insufficient treatments. The epithelial to mesenchymal transition (EMT) has been recognized as a driver of PDAC progression. Also, in recent years, endoplasmic reticulum (ER) stress has been correlated with PDAC. Unfolded protein response (UPR) is the main signaling pathway that is activated by ER overload. We aimed to investigate the ER stress response in patient-derived PDAC cells as a potential target for future therapeutic approaches. METHODS Primary PDAC cell cultures were established from resected tumors of PDAC patients. The ER stress in patient-derived PDAC cells as well as in PANC-1 cell line was induced by tunicamycin treatment for 24 h. The ER stress cellular response was evaluated by immunofluorescence microscopy and western blot analysis. We analyzed the expression levels of two signaling molecules involved in canonical UPR: ER chaperone the binding immunoglobulin protein (BiP) and the C/EBP homologous protein (CHOP). Also, we evaluated the expression levels of epithelial (E-) and neural (N-) cadherins as markers of EMT. To assess the chemical fingerprint of PDAC cells under the ER stress, we applied the intact cell matrix assisted laser desorption/ionization - time of flight mass spectrometry (MALDI-TOF MS). RESULTS AND CONCLUSION We characterized the UPR in PDAC patient-derived cells and in PANC-1 cell line at basal level and after induction of ER stress. MALDI-TOF MS was shown as a valuable tool for assessment of PDAC heterogeneity with potential of revealing the unique metabolic signature of the PDAC patients. Acknowledgements: This study was supported by AZV ČR (NU23-08-00241) and by Masaryk University (MUNI/A/1301/2022 and MUNI/11/ACC/3/2022)
Návaznosti
MUNI/A/1301/2022, interní kód MUNázev: Zdroje pro tkáňové inženýrství 13
Investor: Masarykova univerzita, Zdroje pro tkáňové inženýrství 13
MUNI/11/ACC/3/2022, interní kód MUNázev: Bioanalytical quality control of cGMP/ATMP-grade stem cells and progenitors
Investor: Masarykova univerzita, Bioanalytical quality control of cGMP/ATMP-grade stem cells and progenitors, Accelerate
NU23-08-00241, projekt VaVNázev: Vývoj ex-vivo buněčných modelů pro adenokarcinom pankreatu: markery a cíle pro precizní medicínu
Investor: Ministerstvo zdravotnictví ČR, Vývoj ex-vivo buněčných modelů pro adenokarcinom pankreatu: markery a cíle pro precizní medicínu, Podprogram 1 - standardní
VytisknoutZobrazeno: 12. 7. 2024 13:59